|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/14 | |
| A61K 31/4375 | |||
| A61P 25/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2688890 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12723932.5 |
| Date of filing the European patent application | 2012-03-21 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IN2012/000191 |
| Date | 2012-03-21 |
| (87) | Number | WO 2012/127506 |
| Date | 2012-09-27 |
| (30) | Number | Date | Country code |
| 891CH2011 | 2011-03-22 | IN |
| (72) |
BARAWKAR, Dinesh, IN
BENDE, Tanushree, IN
ZAHLER, Robert, US
BANDYOPADHYAY, Anish, IN
SARANGTHEM, Robindro Singh, IN
DOSHI, Jignesh, IN
WAMAN, Yogesh, IN
JADHAV, Rushikesh, IN
SINGH, Umesh Prasad, IN
|
| (73) |
Advinus Therapeutics Limited,
21 & 22, Peenya Industrial Area, Phase II, Bangalore 560058,
IN
|
| (54) | SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF |
| SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF |